Wednesday, May 3, 2023

Eli Lilly Trial Finds Alzheimer’s Drug Can Slow Progress of Disease

Donanemab is not a cure and comes with significant side effects, but patients had longer periods of independent living while on the drug.

from NYT > Top Stories https://ift.tt/u0mKaXS
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

A Wildlife Regulator’s Family Business Had a Permit to Renew. She Stepped In.

Jenifer Chatfield, a top official at the Interior Department, faces scrutiny from ethics experts for actions that could help her family’s bu...